Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03379792 · ClinicalTrials.gov registry record

The Influence of Glycemic Control and Obesity on Energy Balance and Metabolic Flexibility in Type 1 Diabetes

A clinical trial, sponsored by AdventHealth Translational Research Institute.

Completed
Registry status
32
Enrollment target

NCT03379792 is a clinical trial that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03379792 has completed, sponsored by AdventHealth Translational Research Institute.

COMPLETED
Registry status
32 participants
Enrollment target

Study Summary

The purpose of this study is to measure the metabolic phenotype of a range of body weights in individuals with and without type 1 diabetes.

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2018-03-08
Est. Completion 2020-07-20

What the Registry Record Tells You About NCT03379792

The ClinicalTrials.gov registry entry for NCT03379792 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03379792 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03379792 about?

NCT03379792 is a clinical study titled "The Influence of Glycemic Control and Obesity on Energy Balance and Metabolic Flexibility in Type 1 Diabetes". The purpose of this study is to measure the metabolic phenotype of a range of body weights in individuals with and without type 1 diabetes.

What is the current status of trial NCT03379792?

This trial is currently completed. The enrollment target is 32 participants. The study started on 2018-03-08. Estimated completion is 2020-07-20.

Who is sponsoring clinical trial NCT03379792?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.